CATABASIS PHARMACEUTICALS IN's ticker is CATB and the CUSIP is 14875P107. A total of 31 filers reported holding CATABASIS PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $363,000 | -85.6% | 453,740 | -74.6% | 0.00% | -100.0% |
| Q2 2018 | $2,524,000 | +46.5% | 1,787,100 | +87.7% | 0.00% | -50.0% |
| Q1 2018 | $1,723,000 | +146.8% | 952,200 | +103.2% | 0.00% | +100.0% |
| Q4 2017 | $698,000 | +87.6% | 468,700 | +167.2% | 0.00% | – |
| Q3 2017 | $372,000 | +131.1% | 175,400 | +53.2% | 0.00% | – |
| Q2 2017 | $161,000 | +51.9% | 114,500 | +73.2% | 0.00% | – |
| Q1 2017 | $106,000 | – | 66,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 2,680,752 | $2,571,000 | 3.20% |
| Stonepine Capital Management, LLC | 2,400,000 | $2,302,000 | 1.40% |
| SV Health Investors, LLC | 2,857,667 | $2,740,000 | 1.26% |
| Clarus Ventures, LLC | 2,008,192 | $1,925,000 | 0.68% |
| ARMISTICE CAPITAL, LLC | 2,000,000 | $1,918,000 | 0.12% |
| FEDERATED HERMES, INC. | 10,434,000 | $10,006,000 | 0.03% |
| Alyeska Investment Group, L.P. | 1,121,505 | $1,076,000 | 0.01% |
| Alyeska Investment Group, L.P. | 1,000,000 | $959,000 | 0.01% |
| HRT FINANCIAL LP | 24,000 | $23,000 | 0.01% |
| OPPENHEIMER & CO INC | 198,000 | $190,000 | 0.01% |